Acrivon Therapeutics, Inc. (ACRV)

Nasdaq · Pharmaceutical Preparations

What they're doing

Between 2026-06-14 and 2026-09-12, public records show 1 signal for Acrivon Therapeutics, Inc.. Most notable: 2026-06-17: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-12 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Insider purchase
    Blume-Jensen Peter (director) bought $82k of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-08-31Levin MichaelaofficerA30,0000$0
2026-08-25Blume-Jensen Peter; Masson KristinadirectorS14,0362.21$30,969
2026-08-18Peterson KatharineofficerS1012.01$203
2026-08-18Miller MaryofficerS1852.01$372
2026-08-18Gamelin ErickofficerS4002.01$804
2026-08-18Devroe EricofficerS6042.01$1,214
2026-08-18Blume-Jensen Peter; Masson KristinadirectorS1,2292.01$2,470
2026-08-18Blume-Jensen Peter; Masson KristinadirectorS4842.01$973
2026-08-04Levy Adam D.officerS1,1421.57$1,793
2026-07-21Miller MaryofficerS5731.76$1,008
2026-05-21Masson KristinadirectorF13,7291.79$24,575
2026-05-21Blume-Jensen Peter; Masson KristinadirectorF13,7291.79$24,575
2026-05-18RA Capital Nexus Fund II, L.P.directorA9,3660$0
2026-05-18TOMSICEK MICHAEL JOHNdirectorA9,3660$0
2026-05-18Shacham SharondirectorA9,3660$0
2026-05-18Palani SanthoshdirectorA9,3660$0
2026-05-18Magovcevic-Liebisch IvanadirectorA9,3660$0
2026-05-18DiRocco DerekdirectorA9,3660$0
2026-05-18BAUM CHARLES MdirectorA9,3660$0
2026-05-18Peterson KatharineofficerA14,2270$0
2026-05-18Mirza Mansoor RazaofficerA38,8170$0
2026-05-18Miller MaryofficerA49,8300$0
2026-05-18Levy Adam D.officerA46,1670$0
2026-05-18Gamelin ErickofficerA38,5840$0
2026-05-18Devroe EricofficerA72,9810$0
2026-05-18Blume-Jensen PeterdirectorA72,7060$0
2026-05-18Blume-Jensen PeterdirectorA180,0950$0
2026-05-18RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Kolchinsky Peter; Shah Rajeev M.directorA9,3660$0
2026-05-18TOMSICEK MICHAEL JOHNdirectorA9,3660$0
2026-05-18Shacham SharondirectorA9,3660$0
2026-05-18Palani SanthoshdirectorA9,3660$0
2026-05-18Magovcevic-Liebisch IvanadirectorA9,3660$0
2026-05-18DiRocco DerekdirectorA9,3660$0
2026-05-18BAUM CHARLES MdirectorA9,3660$0
2026-05-18Peterson KatharineofficerA14,2270$0
2026-05-18Mirza Mansoor RazaofficerA38,8170$0
2026-05-18Miller MaryofficerA49,8300$0
2026-05-18Levy Adam D.officerA46,1670$0
2026-05-18Gamelin ErickofficerA38,5840$0
2026-05-18Devroe EricofficerA72,9810$0
2026-05-18Blume-Jensen Peter; Masson KristinadirectorA180,0950$0
2026-05-18Blume-Jensen Peter; Masson KristinadirectorA72,7060$0
2026-05-14Peterson KatharineofficerF991.92$190
2026-05-14Miller MaryofficerF1841.92$353
2026-05-14Gamelin ErickofficerF4041.92$776
2026-05-14Devroe EricofficerF6131.92$1,177
2026-05-14Blume-Jensen PeterdirectorF1,2531.92$2,406
2026-05-14Blume-Jensen PeterdirectorF4901.92$941
2026-05-14Peterson KatharineofficerF991.92$190
2026-05-14Miller MaryofficerF1841.92$353

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

  • 2026-09-02 4
  • 2026-09-02 3
  • 2026-08-27 4
  • 2026-08-25 144
  • 2026-08-20 4
  • 2026-08-20 4
  • 2026-08-20 4
  • 2026-08-20 4
  • 2026-08-20 4
  • 2026-08-13 SCHEDULE 13G/A
  • 2026-08-12 S-8
  • 2026-08-12 8-K
  • 2026-08-12 10-Q
  • 2026-08-06 4
  • 2026-07-23 4
  • 2026-06-22 4
  • 2026-06-22 4
  • 2026-06-22 4
  • 2026-06-22 4
  • 2026-06-22 4